oxaliplatin

The drug is used for adjuvant therapy of stage III colorectal cancer after tumor removal, as well as for the treatment of metastatic colorectal cancer (usually in combination with other drugs).

Form: concentrate for infusion solution

ATC: L01XA03

Manufacturer: Medac Gesellschaft für klinische Spezialpräparate mbH (manufacturer responsible for batch release, labeling and secondary packaging)

The drug is used for adjuvant therapy of stage III colorectal cancer (after complete tumor removal), as well as for the treatment of metastatic colorectal cancer.

Form: concentrate for infusion solution

ATC: L01XA03

Manufacturer: Kilu Pharmaceutical (Hainan) Co., Ltd.

The drug is used in combination with 5-fluorouracil and folinic acid for adjuvant therapy of stage III colorectal cancer (after tumor removal) and for the treatment of metastatic colorectal cancer.

Form: concentrate for infusion solution

ATC: L01XA03

Manufacturer: EBEWE Pharma Ges.m.b.H. Nfg. KG (batch release)

The drug is used for adjuvant therapy of stage III colorectal cancer after complete tumor removal, as well as for the treatment of metastatic colorectal cancer (usually in combination with other drugs, such as 5-fluorouracil and folinic acid).

Form: concentrate for infusion solution

ATC: L01XA03

Manufacturer: Intas Pharmaceuticals Limited (manufacturing of medicinal product, primary and secondary packaging, quality control of batch, export to batch release site)

The drug is used in combination with other agents (5-fluorouracil and folinic acid) for adjuvant therapy of colon cancer after tumor removal, as well as for the treatment of metastatic colorectal cancer.

Form: concentrate for infusion solution

ATC: L01XA03

Manufacturer: AkVida GmbH (batch control, certification and batch release; bulk manufacturing, primary and secondary packaging, batch control)

The drug is used for adjuvant therapy of stage III colorectal cancer following tumor resection, as well as for the treatment of metastatic colorectal cancer.

Form: concentrate for infusion solution

ATC: L01XA03

Manufacturer: Thymoorganon Pharmazie GmbH (manufacturing of medicinal products, primary and secondary packaging, quality control, batch release)

The drug is used for adjuvant therapy of stage III colorectal cancer after tumor removal, as well as for the treatment of metastatic colorectal cancer (usually in combination with other drugs).

Form: concentrate for infusion solution

ATC: L01XA03

Manufacturer: Venus Remedies Limited

The drug is used for adjuvant therapy of stage III colorectal cancer after tumor removal, as well as for the treatment of metastatic colorectal cancer (usually in combination with other drugs).

Form: concentrate for infusion solution

ATC: L01XA03

Manufacturer: Pliva Hrvatska Limited (Quality Control (alternative manufacturer))

The drug is used in combination with 5-fluorouracil and folinic acid for adjuvant therapy of stage III colorectal cancer (after tumor removal) or for the treatment of metastatic colorectal cancer.

Form: solution for injection

ATC: L01XA03

Manufacturer: Venus Remedies Limited

The drug is used for adjuvant therapy of stage III colorectal cancer after tumor removal, as well as for the treatment of metastatic colorectal cancer (usually in combination with other drugs, such as 5-fluorouracil and folinic acid).

Form: concentrate for infusion solution

ATC: L01XA03

Manufacturer: Maylan Laboratories Limited (OTL)